These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 1373778)

  • 21. Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia.
    Inamura S; Ito H; Shinagawa T; Tsutsumiuchi M; Taga M; Kobayashi M; Yokoyama O
    Prostate; 2018 Jul; 78(10):743-752. PubMed ID: 29608020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histologic differences in benign prostate hyperplasia between Chinese and American men.
    Yu EY; Siegal JA; Meyer GE; Ji XR; Ni XZ; Brawer MK
    Prostate; 1997 May; 31(3):175-9. PubMed ID: 9167769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell kinetic in epithelium and stroma of benign prostatic hyperplasia.
    Claus S; Berges R; Senge T; Schulze H
    J Urol; 1997 Jul; 158(1):217-21. PubMed ID: 9186363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transurethral microwave thermotherapy for benign prostatic hyperplasia: relation between clinical response and prostate histology.
    Arai Y; Fukuzawa S; Terai A; Yoshida O
    Prostate; 1996 Feb; 28(2):84-8. PubMed ID: 8604396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study.
    Zlotta AR; Raviv G; Peny MO; Noel JC; Haot J; Schulman CC
    J Urol; 1997 Mar; 157(3):894-9. PubMed ID: 9072594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate.
    Ornstein DK; Rao GS; Smith DS; Andriole GL
    J Urol; 1997 Mar; 157(3):880-3; discussion 883-4. PubMed ID: 9072591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostatic histology in secondary transurethral resection of the prostate.
    Jønler M; Bruskewitz RC
    J Urol; 1995 Jul; 154(1):119-22. PubMed ID: 7539855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphometric analysis of pediatric and nonhyperplastic prostate glands: evidence that BPH is not a unique stromal process.
    Shapiro E; Hartanto V; Perlman EJ; Tang R; Wang B; Lepor H
    Prostate; 1997 Nov; 33(3):177-82. PubMed ID: 9365545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrastructural and biophysical studies on protein conformations of epithelium and stroma in benign prostatic hyperplasia before and after transurethral resection of the prostate.
    Hsu HS; Lin SY; Li MJ; Liang RC
    Ultrastruct Pathol; 2002; 26(3):137-41. PubMed ID: 12184371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer.
    Barclay WW; Woodruff RD; Hall MC; Cramer SD
    Endocrinology; 2005 Jan; 146(1):13-8. PubMed ID: 15471963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial differences in cellular composition of benign prostatic hyperplasia.
    Aoki Y; Arai Y; Maeda H; Okubo K; Shinohara K
    Prostate; 2001 Dec; 49(4):243-50. PubMed ID: 11746270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostatic epithelial and luminal area in the transition zone acini: morphometric analysis in normal and hyperplastic human prostate.
    Babinski MA; Chagas MA; Costa WS; Sampaio FJ
    BJU Int; 2003 Oct; 92(6):592-6. PubMed ID: 14511041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential impact of paired patient-derived BPH and normal adjacent stromal cells on benign prostatic epithelial cell growth in 3D culture.
    Chen W; Pascal LE; Wang K; Dhir R; Sims AM; Campbell R; Gasper G; DeFranco DB; Yoshimura N; Wang Z
    Prostate; 2020 Oct; 80(14):1177-1187. PubMed ID: 32659026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in prostatic stromal composition and benign prostatic hyperplasia].
    Shen W; Mao XM; Lü J; Yao HQ; Deng ZX; Zhao YB; Liu J; Hua W; Wang BQ; Hu WL
    Zhonghua Nan Ke Xue; 2011 Aug; 17(8):703-6. PubMed ID: 21898992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid composition in epithelium and stroma of human benign prostatic hyperplasia.
    Weisser H; Krieg M
    Prostate; 1997 Jan; 30(1):41-6. PubMed ID: 9018334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliot SP; Macdonald R; Wilt TJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004135. PubMed ID: 17943811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The functional role of reactive stroma in benign prostatic hyperplasia.
    Schauer IG; Rowley DR
    Differentiation; 2011; 82(4-5):200-10. PubMed ID: 21664759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of alpha 1 adrenoceptors in the prostate capsule of men with symptomatic and asymptomatic benign prostatic hyperplasia.
    Lepor H; Gup DI; Baumann M; Shapiro E
    Br J Urol; 1991 May; 67(5):493-8. PubMed ID: 1710161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of benign prostatic hyperplasia with 5-alpha-reductase inhibitor: morphological changes in patients who fail to respond.
    Montironi R; Valli M; Fabris G
    J Clin Pathol; 1996 Apr; 49(4):324-8. PubMed ID: 8655710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.